Using human skin grafted mice to identify biomarkers of exposure and study effects of radiation on skin
使用人类皮肤移植小鼠来识别暴露的生物标志物并研究辐射对皮肤的影响
基本信息
- 批准号:10551268
- 负责人:
- 金额:$ 60.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-21 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAgeAntigen-Presenting CellsBiologicalBiological MarkersChildhoodCutaneousDNA RepairDetectionEpitheliumEventExposure toExternal Beam Radiation TherapyGene ExpressionGeneticGoalsHourHumanImmune systemImmunocompromised HostImmunodeficient MouseImmunologic Deficiency SyndromesImmunologicsIndividualInterventionMeasuresMedicalModalityModelingMorphologyMusNeonatalNuclear AccidentsPhasePhenotypePopulationPopulation HeterogeneityProbabilityProteinsProxyRadiationRadiation AccidentsRadiation ToleranceRadiation exposureRapid screeningReactive Oxygen SpeciesRiskSamplingSiteSkinSkin graftT-LymphocyteTestingTissuesValidationVisualbiomarker discoverybiomarker identificationbiomarker validationcohortinnovationirradiationmedical attentionmouse modelneonatal humanpenis foreskinpoint of care testingpredictive markerradiation detectorradiation effectradiation riskradiation-induced injuryradiation-induced tissue damagerisk predictionstem cell populationtissue injuryvascular bed
项目摘要
Summary/Abstract
In the event of a large scale radiologic or nuclear event, the immediate needs are to discriminate exposed
individuals from the worried well and identify individuals at risk for radiation-induced tissue damage. Humans
vary in their sensitivity to radiation-induced tissue injury, the factors that control radiation sensitivity are not fully
understood, and there are no biomarkers to identify individuals at risk for radiation-induced tissue damage. The
skin is an immunologically active barrier tissue that will be impacted by all types of external radiation events.
Skin is visually observable, accessible to non-invasive testing and easily sampled, making it amenable to a
variety of testing modalities. We propose to irradiate and study living, immunologically intact human skin grafts
on immunodeficient NSG mice to identify biomarkers that detect exposure to radiation and predict radiation
induced tissue damage. In Aim 1, we will study the effects of irradiation on adult human skin grafts carried by
NSG mice. We will study DNA damage repair proteins, reactive oxygen species, epithelial barrier function and
gene expression changes in adult human skin grafts exposed to 0, 0.5, 1.0, 2.0 or 5.0 Gy irradiation. We will
identify biomarkers that detect radiation exposure within 24 hours of exposure (Phase I), remain detectable
longer term and/or correlate with later tissue injury (Phase II) and we will validate these biomarkers in a
separate validation cohort of 30 human skin donors (Phase III). In Aim 2, we will study the effects of irradiation
on human neonatal foreskin grafts, a tissue that contains antigen presenting cells but lacks T cells, as a model
for both pediatric and immunocompromised populations. We will test biomarkers identified in Aim 1 for their
ability to detect radiation exposure within 24 hours and to predict tissue injury in neonatal foreskin. If
necessary, we will identify new biomarkers for use in pediatric and immunocompromised populations. In Aim 3,
we will develop rapid point-of-care tests to detect the biomarkers we identify in Aims 1 and 2. The skin is an
accessible tissue that can be studied as a proxy to predict the risk of radiation-induced injury at other tissue
sites. By studying immunologically intact skin from a diverse population of human donors, we will identify
biomarkers that are useful in i) humans, ii) a diverse, outbred population with differing sensitivities to radiation,
and iii) pediatric and immunocompromised populations. Identification of biomarkers that predict subsequent
tissue damage in skin will identify radiation sensitive individuals. Our point-of-care tests have the potential to
rapidly screen potentially exposed populations and identify individuals who are at risk for tissue damage and
will require further medical attention.
摘要/摘要
如果发生大规模的放射线或核事件,则直接需求是区分暴露
来自担心的个体,并确定有辐射引起的组织损伤风险的个体。人类
它们对辐射诱导的组织损伤的敏感性不同,控制辐射敏感性的因素不是完全
理解,并且没有生物标志物可以识别有辐射引起的组织损伤风险的个体。这
皮肤是一种免疫主动的屏障组织,将受到所有类型的外部辐射事件的影响。
皮肤在视觉上可以观察到,可用于非侵入性测试并易于采样,使其适合于
多种测试方式。我们建议照射和研究生活,免疫学完整的人类皮肤移植物
在免疫缺陷的NSG小鼠上,以识别检测到辐射暴露并预测辐射的生物标志物
诱导组织损伤。在AIM 1中,我们将研究辐射对成人人类皮肤移植的影响
NSG小鼠。我们将研究DNA损伤修复蛋白,活性氧,上皮屏障功能和
成人人类皮肤移植物的基因表达变化,暴露于0、0.5、1.0、2.0或5.0 Gy辐照。我们将
识别在暴露后24小时内检测到辐射暴露的生物标志物(I期)仍可检测到
长期和/或与以后的组织损伤相关(II期),我们将在A中验证这些生物标志物
单独的验证队列30人皮肤供体(第三阶段)。在AIM 2中,我们将研究辐射的影响
在人类新生儿包皮移植物上,一种包含抗原呈现细胞但缺乏T细胞的组织作为模型
针对小儿和免疫功能低下的人群。我们将测试AIM 1中确定的生物标志物
能够在24小时内检测辐射暴露并预测新生儿包皮中的组织损伤。如果
有必要的是,我们将确定用于小儿和免疫功能低下的人群中的新生物标志物。在AIM 3中,
我们将开发快速的护理测试,以检测目标1和2中我们识别的生物标志物。皮肤是一种
可访问的组织可以作为代理,以预测其他组织辐射诱导的损伤的风险
站点。通过研究来自各种人类捐助者的免疫学完整皮肤,我们将确定
在i)人类中有用的生物标志物,ii)多种多样的人群,对辐射的敏感性不同,
iii)小儿和免疫功能低下的人群。识别预测随后的生物标志物
皮肤的组织损伤将识别辐射敏感的个体。我们的护理点测试有可能
迅速筛查潜在暴露的人群,并确定面临组织损伤风险的人
将需要进一步的医疗护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rachael Ann Clark其他文献
Rachael Ann Clark的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rachael Ann Clark', 18)}}的其他基金
Skin Inflammation in Human Health and Disease, 2021
人类健康和疾病中的皮肤炎症,2021
- 批准号:
10222899 - 财政年份:2021
- 资助金额:
$ 60.92万 - 项目类别:
Generation of robust resident memory T cells in barrier tissues through skin vaccination
通过皮肤疫苗接种在屏障组织中生成强大的常驻记忆 T 细胞
- 批准号:
10408492 - 财政年份:2021
- 资助金额:
$ 60.92万 - 项目类别:
Optimizing pre-analytic sample handling for high throughput TCR sequencing in cutaneous T cell lymphoma
优化皮肤 T 细胞淋巴瘤高通量 TCR 测序的分析前样品处理
- 批准号:
10688079 - 财政年份:2020
- 资助金额:
$ 60.92万 - 项目类别:
Optimizing pre-analytic sample handling for high throughput TCR sequencing in cutaneous T cell lymphoma
优化皮肤 T 细胞淋巴瘤高通量 TCR 测序的分析前样品处理
- 批准号:
10814026 - 财政年份:2020
- 资助金额:
$ 60.92万 - 项目类别:
Optimizing pre-analytic sample handling for high throughput TCR sequencing in cutaneous T cell lymphoma
优化皮肤 T 细胞淋巴瘤高通量 TCR 测序的分析前样品处理
- 批准号:
10053369 - 财政年份:2020
- 资助金额:
$ 60.92万 - 项目类别:
Optimizing pre-analytic sample handling for high throughput TCR sequencing in cutaneous T cell lymphoma
优化皮肤 T 细胞淋巴瘤高通量 TCR 测序的分析前样品处理
- 批准号:
10247804 - 财政年份:2020
- 资助金额:
$ 60.92万 - 项目类别:
Optimizing pre-analytic sample handling for high throughput TCR sequencing in cutaneous T cell lymphoma
优化皮肤 T 细胞淋巴瘤高通量 TCR 测序的分析前样品处理
- 批准号:
10424577 - 财政年份:2020
- 资助金额:
$ 60.92万 - 项目类别:
Using human skin grafted mice to identify biomarkers of exposure and study effects of radiation on skin
使用人类皮肤移植小鼠来识别暴露的生物标志物并研究辐射对皮肤的影响
- 批准号:
10112825 - 财政年份:2020
- 资助金额:
$ 60.92万 - 项目类别:
Reversing immune evasion and enhancing immune detection with topical resiquimod
使用外用瑞西莫德逆转免疫逃避并增强免疫检测
- 批准号:
10241428 - 财政年份:2018
- 资助金额:
$ 60.92万 - 项目类别:
Generation of Robust Resident Memory T cells in Barrier Tissues through Skin Vaccination
通过皮肤疫苗接种在屏障组织中生成强大的常驻记忆 T 细胞
- 批准号:
10064958 - 财政年份:2016
- 资助金额:
$ 60.92万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Early Life Pulmonary Infection, Microbiome and Trained Innate Immunity
生命早期肺部感染、微生物组和经过训练的先天免疫
- 批准号:
10677304 - 财政年份:2023
- 资助金额:
$ 60.92万 - 项目类别:
Immunometabolic consequences of alcohol-induced mesenteric lymphatic dyshomeostasis
酒精引起的肠系膜淋巴稳态失调的免疫代谢后果
- 批准号:
10679999 - 财政年份:2023
- 资助金额:
$ 60.92万 - 项目类别:
Project 1: The impact of innate immune responses on the development of broadly neutralizing antibodies by vaccination
项目 1:先天免疫反应对通过疫苗接种产生广泛中和抗体的影响
- 批准号:
10731281 - 财政年份:2023
- 资助金额:
$ 60.92万 - 项目类别:
Vaccine-induced SARS-CoV-2-specific T cell responses in patients with X-linked Agammaglobulinemia
X 连锁无丙种球蛋白血症患者中疫苗诱导的 SARS-CoV-2 特异性 T 细胞反应
- 批准号:
10593523 - 财政年份:2023
- 资助金额:
$ 60.92万 - 项目类别:
7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination
7HP349,一种口服整合素激活剂,可增强暴露前流感疫苗接种的有效性
- 批准号:
10693536 - 财政年份:2023
- 资助金额:
$ 60.92万 - 项目类别: